CIK 0001660334 · Non-accelerated filer<br>Smaller reporting company
Verrica Pharmaceuticals Inc.
Sign in to watch- Ticker
- VRCA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463137900
- Phone
- 484-453-3300
- Business address
- 44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
- Open-market buys, last 90 days
- $109,690
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$109,690. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-24 | Goldenberg Gary Chief Medical Officer | Sale | −28,699 | $4.83 | $139K | 70,110 |
| 2023-07-24 | Bonaccorso Joe Chief Commercial Officer | Sale | −38,262 | $4.83 | $185K | 62,738 |
| 2023-07-24 | White Ted President and CEO | Sale | −50,677 | $4.83 | $245K | 128,789 |
| 2023-07-24 | Manning Paul B Director | Purchase | +200,000 | $5.02 | $1.0M | 7,851,128 |
| 2023-07-21 | Hayes Christopher G. Chief Legal Officer | Grant or award | +100,000 | 115,714 | ||
| 2023-07-21 | Goldenberg Gary Chief Medical Officer | Grant or award | +75,000 | 98,809 | ||
| 2023-07-21 | Bonaccorso Joe Chief Commercial Officer | Grant or award | +100,000 | 101,000 | ||
| 2023-07-21 | White Ted President and CEO | Grant or award | +150,000 | 179,466 | ||
| 2023-06-08 | Ballaron Craig Director | Grant or award · Stock Option (right to buy) | +10,384 | 10,384 | ||
| 2023-06-08 | Eichenfield Lawrence Director | Grant or award · Stock Option (right to buy) | +10,384 | 10,384 | ||
| 2023-06-08 | Nguyen Diem Director | Grant or award · Stock Option (right to buy) | +10,384 | 10,384 | ||
| 2023-06-08 | PRYGOCKI MARK A SR Director | Grant or award · Stock Option (right to buy) | +10,384 | 10,384 | ||
| 2023-03-01 | White Ted President and CEO | Grant or award · Employee Stock Option (right to buy) | +240,000 | 240,000 | ||
| 2023-03-01 | Bonaccorso Joe Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2023-03-01 | Kohler Terry Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2023-03-01 | Goldenberg Gary Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2023-03-01 | Hayes Christopher G. Chief Legal Officer | Grant or award · Employee Stock Option (right to buy) | +135,000 | 135,000 | ||
| 2022-07-11 | Hayes Christopher G. Chief Legal Officer | Purchase | +7,500 | $3.40 | $26K | 15,714 |
| 2022-07-05 | White Ted President and CEO | Purchase | +7,500 | $2.10 | $16K | 29,466 |
| 2022-07-05 | Hayes Christopher G. Chief Legal Officer | Purchase | +5,714 | $2.10 | $12K | 8,214 |
Page 7 of 8 · 154 trades